Pharmacogenetics Testing in Psychiatry Market Enhances Personalized Mental Health Treatments
" According to the latest report published by Data Bridge Market Research, the Pharmacogenetics Testing in Psychiatry/Depression Market CAGR Value The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period...
0 Comentários 0 Compartilhamentos 19 Visualizações 0 Anterior
FSB Mart https://fsbmart.com